Eléments de l'association

	Andrew Lees (neurologue)	15
	Dose-Response Relationship, Drug	34
	Andrew Lees (neurologue) *Sauf* Dose-Response Relationship, Drug"	12
	Dose-Response Relationship, Drug *Sauf* Andrew Lees (neurologue)"	31
	Andrew Lees (neurologue) Et Dose-Response Relationship, Drug	3
	Andrew Lees (neurologue) Ou Dose-Response Relationship, Drug	46
	*Corpus*	679

List of bibliographic references

Number of relevant bibliographic references: 3.

Ident.	Authors (with country if any)	Title
000267	Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni]	Adherence to antiparkinson medication in a multicenter European study
000369	Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni]	Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study
000569	Rascol [France] ; Kasia Sieradzan [Royaume-Uni] ; Hélène Peyro-Saint-Paul [France] ; Claire Thalamas [France] ; Christine Brefel-Courbon [France] ; Jean Michel Senard [France] ; Philippe Ladure [France] ; Jean Louis Montastruc [France] ; Andrew Lees (neurologue) [Royaume-Uni]	Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024